中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
25期
50-51,52
,共3页
高斐%赵浩亮%韩建立%郗光霞
高斐%趙浩亮%韓建立%郗光霞
고비%조호량%한건립%치광하
肥胖症%腹腔镜袖状胃切除术%近期疗效
肥胖癥%腹腔鏡袖狀胃切除術%近期療效
비반증%복강경수상위절제술%근기료효
Obesity%Laparoscopic sleeve gastrectomy%Short-term effect
目的:探讨腹腔镜袖状胃切除术(LSG)治疗肥胖症及相关代谢性疾病的近期疗效。方法:收集并评价2013年2月-2014年5月在本院行LSG术的7例肥胖症患者的术前资料及术后6个月的随访资料,术前患者的平均体重、体重指数(BMI)、超重体重(EBW)分别为100~140 kg、31.56~56.50 kg/m2、27.13~81.53 kg。结果:所有手术均在腹腔镜下顺利完成,无中转开腹,术后无严重并发症。术后1、2、3、6个月随访,体重指数(BMI)明显减少(P<0.05),超重体重百分比(EWL%)呈上升趋势。结论:腹腔镜袖状胃切除术治疗肥胖症减重效果明显,肥胖症相关代谢性疾病也有了明显改善。
目的:探討腹腔鏡袖狀胃切除術(LSG)治療肥胖癥及相關代謝性疾病的近期療效。方法:收集併評價2013年2月-2014年5月在本院行LSG術的7例肥胖癥患者的術前資料及術後6箇月的隨訪資料,術前患者的平均體重、體重指數(BMI)、超重體重(EBW)分彆為100~140 kg、31.56~56.50 kg/m2、27.13~81.53 kg。結果:所有手術均在腹腔鏡下順利完成,無中轉開腹,術後無嚴重併髮癥。術後1、2、3、6箇月隨訪,體重指數(BMI)明顯減少(P<0.05),超重體重百分比(EWL%)呈上升趨勢。結論:腹腔鏡袖狀胃切除術治療肥胖癥減重效果明顯,肥胖癥相關代謝性疾病也有瞭明顯改善。
목적:탐토복강경수상위절제술(LSG)치료비반증급상관대사성질병적근기료효。방법:수집병평개2013년2월-2014년5월재본원행LSG술적7례비반증환자적술전자료급술후6개월적수방자료,술전환자적평균체중、체중지수(BMI)、초중체중(EBW)분별위100~140 kg、31.56~56.50 kg/m2、27.13~81.53 kg。결과:소유수술균재복강경하순리완성,무중전개복,술후무엄중병발증。술후1、2、3、6개월수방,체중지수(BMI)명현감소(P<0.05),초중체중백분비(EWL%)정상승추세。결론:복강경수상위절제술치료비반증감중효과명현,비반증상관대사성질병야유료명현개선。
Objective: To evaluate the short term effect of laparoscopic sleeve gastrectomy (LSG) for the treatment of obesity and related metabolic diseases.Method: 7 obesity patients perioperative data and postoperative follow-up data of 6 months, who underwent LSG surgery in our department from February 2013 to May 2014 were selected. Mean preoperative body weight, body mass index (BMI), and exceed body weight (EBW) was 100-140 kg, 31.56-56.50 kg/m2, 27.13-81.53 kg. Result: All the operations were successfully completed laparoscopically, without conversion to open surgery, no serious postoperative complications. At 1, 2, 3, and 6 months following up after surgery, BMI significantly reduced (P<0.05). The percentage of EBW loss (EWL%) showed an rising trend.Conclusion: The effect of LSG for obesity is obvious, and obesity related metabolic diseases has improved.